Industries › Healthcare › Pharmaceutical Preparations
Pharmaceutical Preparations
The 514 US-listed Pharmaceutical Preparations companies we cover, ranked by market cap. Updated
The largest Pharmaceutical Preparations companies by market cap: Lilly (Eli), Johnson & Johnson, Beone Medicines Ltd., AbbVie, Merck. Together, the 505 companies we cover report $650.2B in combined trailing-twelve-month revenue — the sum of covered companies' reported revenue, not an industry market-size estimate.
Pharmaceutical Preparations heatmap
Tile size is market cap; color is the latest daily change.
Technical signals in Pharmaceutical Preparations
Chart conditions currently in force among Pharmaceutical Preparations stocks — each opens the screener filtered to Pharmaceutical Preparations + that signal.
Golden Cross Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks whose 50-day moving average has just crossed above the 200-day — a widely-watched long-term trend signal. A live technical scan, refreshed daily — informational, not advice.
Golden Cross screener →New 52-Week High Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks that just printed a fresh 52-week high. A live technical scan, refreshed daily — informational, not advice.
52-week-high screener →Oversold Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks with a 14-day RSI below 30, the level chartists call oversold. A live technical scan, refreshed daily — informational, not advice.
Oversold screener →Overbought Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks with a 14-day RSI above 70 (overbought territory). A live technical scan, refreshed daily — informational, not advice.
Overbought screener →RSI Bounce Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks where the 14-day RSI has just turned up out of oversold. A live technical scan, refreshed daily — informational, not advice.
RSI-bounce screener →Near 52-Week High Pharmaceutical Preparations Stocks
Pharmaceutical Preparations stocks trading within 10% of their 52-week high. A live technical scan, refreshed daily — informational, not advice.
52-week-high screener →Companies
| LLY | Lilly (Eli) | 1159.54 | -0.02% | $1.09T |
| JNJ | Johnson & Johnson | 278.28 | +1.04% | $670.6B |
| ONC | Beone Medicines Ltd. | 362.54 | +0.23% | $535.9B |
| ABBV | AbbVie | 260.21 | -0.57% | $459.8B |
| MRK | Merck | 152.32 | +0.44% | $375.8B |
| ABT | Abbott Laboratories | 108.80 | -1.50% | $189.5B |
| PFE | Pfizer | 28.81 | -0.76% | $164.2B |
| VRTX | Vertex Pharmaceuticals | 558.12 | +0.24% | $141.5B |
| BMY | Bristol Myers Squibb | 68.08 | +0.62% | $139.1B |
| REGN | Regeneron Pharmaceuticals | 843.50 | -1.02% | $87.2B |
| TEVA | Teva Pharmaceutical Industries Ltd | 36.60 | -2.32% | $42.6B |
| ALNY | Alnylam Pharmaceuticals | 264.30 | -1.10% | $35.4B |
| ZTS | Zoetis | 76.27 | +0.16% | $31.5B |
| RPRX | Royalty Pharma Plc | 63.88 | +1.24% | $28.2B |
| INSM | Insmed Incorporated | 126.69 | +0.04% | $27.7B |
| ROIV | Roivant Sciences Ltd. | 34.41 | +0.64% | $24.9B |
| UTHR | United Therapeutics Corp | 490.23 | -0.41% | $21.0B |
| VTRS | Viatris | 16.94 | -0.88% | $19.5B |
| JAZZ | Jazz Pharmaceuticals Plc | 247.64 | +0.86% | $16.1B |
| BBIO | Bridgebio Pharma, Inc. | 75.39 | -1.51% | $14.7B |
| BMRN | Biomarin Pharmaceutical Inc | 66.42 | -0.87% | $12.9B |
| MDGL | Madrigal Pharmaceuticals, Inc. | 542.46 | -0.81% | $12.5B |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 86.53 | +1.34% | $12.2B |
| ELAN | Elanco Animal Health Inc | 24.42 | -1.03% | $12.2B |
| CORT | Corcept Therapeutics Inc | 112.82 | +2.08% | $12.2B |
| AXSM | Axsome Therapeutics, Inc. | 208.47 | -0.69% | $10.9B |
| CYTK | Cytokinetics Inc | 73.94 | +2.73% | $10.3B |
| GPCR | Structure Therapeutics Inc. | 47.37 | -0.88% | $10.1B |
| PRAX | Praxis Precision Medicines, Inc. | 354.92 | -0.78% | $9.9B |
| IONS | Ionis Pharmaceuticals Inc | 58.13 | -5.21% | $9.7B |
| PTGX | Protagonist Therapeutics, Inc | 148.74 | +1.90% | $9.6B |
| CRNX | Crinetics Pharmaceuticals, Inc. | 84.96 | +0.13% | $9.0B |
| TGTX | Tg Therapeutics, Inc. | 56.69 | -0.42% | $8.7B |
| ALKS | Alkermes Plc. | 46.87 | -1.81% | $7.9B |
| SYRE | Spyre Therapeutics, Inc. | 87.25 | +0.21% | $7.7B |
| RYTM | Rhythm Pharmaceuticals, Inc. | 104.82 | -0.51% | $7.2B |
| MIRM | Mirum Pharmaceuticals, Inc. | 100.60 | +0.87% | $6.5B |
| TVTX | Travere Therapeutics, Inc. | 66.50 | -1.06% | $6.3B |
| KNSA | Kiniksa Pharmaceuticals International, Plc | 80.42 | +0.65% | $6.2B |
| LQDA | Liquidia Corp | 68.61 | -1.54% | $6.1B |
| COGT | Cogent Biosciences, Inc. | 34.93 | +1.11% | $6.1B |
| DNTH | Dianthus Therapeutics, Inc. /De/ | 107.74 | +1.25% | $6.0B |
| ORKA | Oruka Therapeutics, Inc. | 90.94 | -0.89% | $6.0B |
| PTCT | Ptc Therapeutics, Inc. | 71.41 | -0.46% | $6.0B |
| XENE | Xenon Pharmaceuticals Inc. | 60.40 | +0.34% | $5.8B |
| LGND | Ligand Pharmaceuticals Inc | 289.22 | +0.90% | $5.8B |
| AMRX | Amneal Pharmaceuticals, Inc. | 17.86 | -1.02% | $5.7B |
| ERAS | Erasca, Inc. | 16.28 | -0.55% | $5.7B |
| PBLS | Parabilis Medicines, Inc. | 40.74 | +1.57% | $5.0B |
| ACAD | Acadia Pharmaceuticals Inc | 27.86 | -3.67% | $4.8B |
| DYN | Dyne Therapeutics, Inc. | 24.93 | -0.80% | $4.7B |
| EWTX | Edgewise Therapeutics, Inc. | 41.94 | -0.02% | $4.6B |
| ELVN | Enliven Therapeutics, Inc. | 59.61 | +0.98% | $4.4B |
| MANE | Veradermics, Inc | 98.10 | -0.43% | $4.1B |
| VKTX | Viking Therapeutics, Inc. | 33.99 | +1.45% | $4.0B |
| IDYA | Ideaya Biosciences, Inc. | 39.97 | -0.45% | $3.9B |
| TNGX | Tango Therapeutics, Inc. | 22.76 | +2.11% | $3.8B |
| RCUS | Arcus Biosciences, Inc. | 30.12 | +1.09% | $3.8B |
| AMLX | Amylyx Pharmaceuticals, Inc. | 33.95 | -1.59% | $3.8B |
| OGN | Organon & Co. | 13.78 | +0.00% | $3.6B |
| ABCL | Abcellera Biologics Inc. | 11.56 | +1.76% | $3.5B |
| IMNM | Immunome Inc. | 27.16 | -0.48% | $3.1B |
| IRON | Disc Medicine, Inc. | 79.35 | -0.92% | $3.0B |
| ARQT | Arcutis Biotherapeutics, Inc. | 23.67 | -0.71% | $3.0B |
| MBX | Mbx Biosciences, Inc. | 61.40 | +0.85% | $3.0B |
| SLS | Sellas Life Sciences Group, Inc. | 13.68 | -3.18% | $2.8B |
| ATAI | Ataibeckley Inc. | 7.34 | -0.14% | $2.7B |
| NRIX | Nurix Therapeutics, Inc. | 25.31 | -1.98% | $2.6B |
| NKTR | Nektar Therapeutics | 76.44 | +5.08% | $2.6B |
| VRDN | Viridian Therapeutics, Inc.De | 22.95 | +0.72% | $2.6B |
| SUPN | Supernus Pharmaceuticals, Inc. | 44.00 | -0.12% | $2.6B |
| PGEN | Precigen, Inc. | 7.13 | +1.78% | $2.6B |
| BHC | Bausch Health Companies Inc. | 6.76 | -0.88% | $2.5B |
| VERA | Vera Therapeutics, Inc. | 35.01 | -1.81% | $2.5B |
| MLYS | Mineralys Therapeutics, Inc. | 28.27 | -2.73% | $2.5B |
| PBH | Prestige Consumer Healthcare Inc. | 52.53 | -0.56% | $2.5B |
| HRMY | Harmony Biosciences Holdings, Inc. | 41.85 | -2.39% | $2.4B |
| TRVI | Trevi Therapeutics, Inc. | 17.06 | +0.00% | $2.4B |
| SRPT | Sarepta Therapeutics, Inc. | 22.99 | -0.95% | $2.4B |
| BRVE | Braveheart Bio, Inc. | 26.63 | +1.52% | $2.4B |
| BHVN | Biohaven Ltd. | 15.87 | +1.12% | $2.4B |
| NUVB | Nuvation Bio Inc. | 6.76 | -2.66% | $2.4B |
| OCUL | Ocular Therapeutix, Inc | 10.63 | -2.52% | $2.3B |
| RAPP | Rapport Therapeutics, Inc. | 47.62 | -2.19% | $2.3B |
| PVLA | Palvella Therapeutics, Inc. | 155.41 | +1.35% | $2.2B |
| ZBIO | Zenas Biopharma, Inc. | 32.94 | -0.45% | $2.1B |
| ZYME | Zymeworks Inc. | 29.89 | -3.70% | $2.1B |
| GENB | Generate Biomedicines, Inc. | 16.34 | +0.31% | $2.1B |
| KLRA | Kailera Therapeutics, Inc. | 15.71 | -1.04% | $2.0B |
| PRGO | Perrigo Co Plc | 14.26 | -1.45% | $2.0B |
| XNCR | Xencor Inc | 26.61 | -1.10% | $2.0B |
| AGIO | Agios Pharmaceuticals, Inc. | 33.12 | -2.85% | $2.0B |
| KARD | Kardigan, Inc. | 20.86 | +0.70% | $2.0B |
| STOK | Stoke Therapeutics, Inc. | 30.00 | -1.70% | $1.9B |
| SNDX | Syndax Pharmaceuticals Inc | 20.69 | -0.48% | $1.8B |
| DMRA | Damora Therapeutics, Inc. | 27.97 | -0.85% | $1.7B |
| SEPN | Septerna, Inc. | 36.77 | -1.97% | $1.7B |
| ETON | Eton Pharmaceuticals, Inc. | 59.88 | -3.43% | $1.7B |
| ANAB | Anaptysbio, Inc | 57.55 | +2.99% | $1.7B |
| AVLN | Avalyn Pharma Inc. | 35.38 | -0.63% | $1.6B |
Frequently asked questions
How many Pharmaceutical Preparations companies are there?
We cover 514 US-listed Pharmaceutical Preparations companies as of 2026-09-18, refreshed every trading day.
Who are the largest Pharmaceutical Preparations companies?
By market cap, the largest Pharmaceutical Preparations companies we cover are Lilly (Eli) (LLY), Johnson & Johnson (JNJ), Beone Medicines Ltd. (ONC).
What is the combined market cap of the Pharmaceutical Preparations industry?
The 514 US-listed Pharmaceutical Preparations companies we cover have a combined market capitalization of $4.60 trillion as of 2026-09-18.
What is the total revenue of the Pharmaceutical Preparations industry?
The combined trailing-twelve-month revenue of the US-listed Pharmaceutical Preparations companies we cover is $650.2 billion. This is the sum of covered companies' reported revenue — not an industry market-size estimate.
What is the average dividend yield of Pharmaceutical Preparations companies?
The cap-weighted average dividend yield of the Pharmaceutical Preparations stocks we cover is 2.13%.
Industry classification from SEC EDGAR (SIC) · Databento EQUS.MINI (prices) · combined figures are sums/averages of the US-listed companies we cover. Informational only — not financial advice.